These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 15154877

  • 1. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T, Akizawa T, Koide K, Koshikawa S.
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [Abstract] [Full Text] [Related]

  • 2. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
    Sanaka T, Fujimoto K, Niwayama J, Nishimura H, Naito T, Higuchi C, Akizawa T, Koide K, Koshikawa S.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949
    [Abstract] [Full Text] [Related]

  • 3. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S.
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
    Komiya T, Miura K, Tsukamoto J, Okamura M, Tamada S, Asai T, Tashiro K, Kuwabara N, Iwao H, Yoshikawa J.
    Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibitor and chronic renal failure.
    Sitprija V, Lumlertgul D.
    J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
    [Abstract] [Full Text] [Related]

  • 10. [Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level].
    Nakayama M, Tanno Y, Otsuka Y, Takahashi H, Ikeda M, Katoh N, Yokoyama K, Yamamoto H, Tokutome G, Hosoya T.
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):530-6. PubMed ID: 12476589
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study.
    Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T.
    Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A.
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [Abstract] [Full Text] [Related]

  • 19. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
    Imai E, Takenaka M, Isaka Y, Moriyama T, Akagi Y, Kakuchi J, Fujii T, Ito T, Hori M, Horio M, Syoji T, Tsubakihara Y.
    Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.